Loading group…
Loading group…
Group
| Therapeutics: Respiratory & Pulmonary TherapeuticsRespiratory & Pulmonary Therapeutics | 15 | $114.51B | $1.72T | +1.32% | -1.81% | +6.88% | +20.71% | +7.65% | -2.65% | +1.68% | +8.63% | +83.63% | +249.44% | +3.39% | +62.36% | +3.16% | +1.21% |
| Therapeutics: Radiopharmaceutical TherapeuticsRadiopharmaceutical Therapeutics | 14 | $146.59B | $2.05T | +1.17% | -3.42% | +1.88% | -6.99% | -5.22% | -21.70% | -8.98% | -7.58% | -2.53% | +58.63% | -14.76% | -8.49% | -0.48% | -3.34% |
| Therapeutics: Pain ManagementPain Management | 12 | $204.65B | $2.46T | -2.44% | -0.20% | +1.27% | +3.55% | +0.53% | +5.48% | +12.10% | +14.60% | +53.53% | +96.34% | +11.93% | +49.11% | +2.99% | -3.17% |
| Therapeutics: Immunology & InflammationImmunology & Inflammation | 22 | $174.71B | $3.84T | -0.12% | -1.46% | +1.04% | +11.72% | +0.11% | +2.39% | +17.24% | +24.37% | +86.40% | +138.58% | +14.72% | +93.72% | +0.45% | +2.88% |
| Therapeutics: Renal & Kidney TherapeuticsRenal & Kidney Therapeutics | 13 | $40.42B | $525.41B | -0.42% | -0.49% | -1.54% | -2.96% | -8.09% | -15.85% | -7.96% | +1.36% | +31.07% | +29.97% | -6.84% | +42.38% | -6.23% | -1.93% |
| Therapeutics: Oncology TherapeuticsOncology Therapeutics | 17 | $14.15B | $240.55B | +0.70% | -1.09% | -3.55% | -10.21% | -13.70% | -24.55% | +0.07% | +5.06% | +63.17% | +75.83% | -8.49% | +97.77% | +0.54% | -7.88% |
| Therapeutics: Psychedelic DrugsPsychedelic Drugs | 12 | $572.3M | $6.87B | +2.57% | -3.98% | -6.91% | -20.18% | -21.63% | -38.96% | +14.52% | +19.80% | +19.39% | -31.14% | +9.43% | +46.53% | -3.76% | -17.05% |
| Therapeutics: Healthspan & Aging InterventionsHealthspan & Aging Interventions | 16 | $213.04B | $3.41T | +2.53% | -1.69% | -11.87% | -10.65% | -10.58% | -45.61% | -46.89% | -47.67% | -45.52% | -70.38% | -52.21% | -25.06% | -5.17% | -17.14% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary